Epstein Secrets

From: Vahe Stepanian To: Jeffrey Epstein <jeevacationggmail.com> CC: Daniel AriancDwer im r >, Richard Kahn >, Paul Morris Subject: FMI [C] Date: Wed, 08 Apr 2015 20:56:30 +0000 Classification: Confidential Jeffrey- as you may have seen, Roche announce

ail.com> CC: Daniel AriancDwer im r >, Richard Kahn >, Paul Morris Subject: FMI [C] Date: Wed, 08

, Richard Kahn >, Paul Morris Subject: FMI [C] Date: Wed, 08 Apr 2015 20:56:30 +0000 Classification: Confidential Jeffrey- as you may have seen, Roche announced preliminary results of its tender offer for up to 15.6mm FMI shares @ $50.00/sh: —17.48mm FMI common stock was validly tendered. The stock

From: Richard Kahn < To: "jeffrey E." <[email protected]> Subject: Fwd: BMY Fails in 1L Lung (-17%)...MRK to Rally (+10%)...+ve Read-thru for AZN/Roche Date: Fri

From: Richard Kahn < To: "jeffrey E." <[email protected]> Subj

OS endpoints. BMY is trading down 18% on the back of the results while MRK is trading +12%. Note AZN has reversed earlier losses (now +1.3%) while Roche is +0.6%. Note that MRK's data from KN-024 had PDL1 tumor expression >50% vs BMY's trial which was >5%....could be an issue of trial design here.

From: Vahe Stepanian To: Jeffrey Epstein <[email protected]> Morris Stewart Oldfield , Richard Kahn , Ariane Dwyer , Paul CC: Daniel Sabba Subject: AAVL: (BN) Avalanche Drops as Gene Therapy Trial Miss High Expectation [C] Date: Tue, 16 Jun 201

[email protected]> Morris Stewart Oldfield , Richard Kahn , Ariane Dwyer , Paul CC: Daniel Sabba Subjec

If approved, AVA-101 would be the first gene therapy for the condition and could replace current options made by Regeneron Pharmaceuticals Inc. and Roche that require monthly injections in the eye. Avalanche's treatment theoretically fixes disease-causing genetic code with only one injection. The trea

From: Paul Barrett < Sent: Friday, July 13, 2018 1:56 PM To: jeffrey E. Cc: Richard Kahn Subject: FW: Updates Regarding 81— can we officially tender?<=o:p> Paul Barrett Alpha Group Capital LLC 142 W 57th Street, 11th Floor,=New York

y 13, 2018 1:56 PM To: jeffrey E. Cc: Richard Kahn Subject: FW: Updates Regarding 81— can we offi

Sent: Monday, July 09, 2018 7:47 PM To: 'jeffrey E.' <[email protected]> Cc: Subject: Updates Jeffrey 1. Can we officially accept the FMI/Roche tender at $137/share in cash? 2. I bought $1MM of the Exela bonds at $102.875 (9.12% y=eld). Will work another $1MM at a $102.50. 3. SPY calls =l

From: Richard Kahn Sent: Monday, January 12, 2015 12:31 PM To: Jeffrey Epstein Subject: FMI Both you and Boris will be ha=py today FMI indicated open at 50 as R

From: Richard Kahn Sent: Monday, January 12, 2015 12:31 PM To: J

n Sent: Monday, January 12, 2015 12:31 PM To: Jeffrey Epstein Subject: FMI Both you and Boris will be ha=py today FMI indicated open at 50 as Roche taking = majority stake http://www.forbes.com/sitegmatthewherper/2015/01/12hoche-spends-1-03-bil lion-for-majority-stake-in-cancer- genom ics-fi rm/

From: Richard Kahn < Sent: Monday, January 12, 2015 1:05 PM To: Jeffrey E. Subject: Re: FMI Sorry for confusion are we holding or s=lling portion or all of stock

From: Richard Kahn < Sent: Monday, January 12, 2015 1:05 PM To:

Jan 12, 2015 at 8:30 AM, Richard Kahn <=pan dir="ltra <mailto: > wrote: Both you and Boris will be happy today<=div> FMI indicated open at 50 as Roche taking a majority=stake http://www.forbes.com/sites/matthewherper/2=15/01/12/roche-spends-1.03-bi II ion-for-majority- stake-in-cancer-genomics-fi=m

From: jeffrey E. <[email protected]> Sent: Monday, January 12, 2015 1:29 PM To: Richard Kahn Subject: Re: FMI Hold On Monday, January 12, 2015, Richard Kahn wrote: Sorry for confusion are we h=lding or selling portion or all of stock.

: Monday, January 12, 2015 1:29 PM To: Richard Kahn Subject: Re: FMI Hold On Monday, January 12,

l of stock. Sent from my iPhone=/div> On Jan 12, 2015, at 7:41 AM, jeffrey E. < Both you and Boris will be happy today FMI =ndicated open at 50 as Roche taking a majority stake <=iv>http://www.forbes.com/sites/matthewherper/2015/01/12/roche-spends-1-=3-billion-for-majority-stake-in-cancer- genomics-f

8 (Fla. I DCA 1997), quoting Blatt . Green Rose, Kahn & Piotrkowski, 456 So.2d 949 (Fla. 3d DCA 1984).

back to state court if any of the properly joined parties in interest are citizens of the state in which the suit was filed. See Lincoln Prop. Co.'. Roche, 546 U.S. 81, 126 S.Ct. 606, 613, 163 L.Ed.2d 415 (2005) (citing 28 U.S.C. § 1441(b)). Such a remand is the necessary corollary of a federal distri